TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27288835

Group type: EXPERIMENTAL
Intervention: 24IU oxytocin
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Cognitive taxation (taxed vs. not taxed)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 194
Study: 26340941

Group type: EXPERIMENTAL
Intervention: Systematic cross-checkings between emergency physicians
Number of subjects: 1584

Group type: COMPARATOR
Intervention: Usual care (control period)
Number of subjects: 1584
Study: 24206639

Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment (weekly group-based for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cognitive remediation treatment
Number of subjects: 40
Study: 21406514

Group type: EXPERIMENTAL
Intervention: Adaptive support ventilation (ASV)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV)
Number of subjects: 97
Study: 19517247

Group type: EXPERIMENTAL
Intervention: Memantine at a dose of 20 mg/day
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study: 17222627

Group type: EXPERIMENTAL
Intervention: Prior radical prostatectomy
Number of subjects: 1238

Group type: COMPARATOR
Intervention: No prior radical prostatectomy
Number of subjects: 1238
Study: 15881107

Group type: EXPERIMENTAL
Intervention: Strepfen (flurbiprofen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 60
Study: 12469544

Group type: EXPERIMENTAL
Intervention: Multicomponent medication adherence intervention (behavioral strategies, simplified patient information, social support, cognitive‐behavioral therapy, nursing)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Multicomponent medication adherence intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 33
Study: 9802635

Group type: EXPERIMENTAL
Intervention: Oral tetravalent rotavirus vaccine (RV‐TV)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 8575610

Group type: EXPERIMENTAL
Intervention: Fundus III oral liquid (10ml/time P.O. t.i.d. for 1 month)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Urokinase (10,000 u + 5% glucose 500ml/day i.v. drip for 5 days, followed by another 5 days)
Number of subjects: 80
Study: 2197910

Group type: EXPERIMENTAL
Intervention: Inhaled pentamidine (8 mg/kg body weight)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Intravenous pentamidine (4 mg/kg body weight)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inhaled pentamidine
Number of subjects: 21
Study: 92830

Group type: EXPERIMENTAL
Intervention: Neutron treatment (full course of 16 Gy)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Neutron treatment (reduced doses of 10 to 14 Gy)
Number of subjects: 59
Study: 30539236

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB) angioplasty
Number of subjects: 355

Group type: COMPARATOR
Intervention: Plain Old Balloon Angioplasty (POBA)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Bailout stenting in POBA group
Number of subjects: 355
Study: 28009692

Group type: EXPERIMENTAL
Intervention: 10,600 nm ablative fractional carbon dioxide (CO2) laser treatment (3 sessions)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (untreated half of the scar)
Number of subjects: 9
Study: 25832340

Group type: EXPERIMENTAL
Intervention: High total flavonoid intake (total flavonoidUSDA)
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: High total flavonoid intake (total flavonoidPE)
Number of subjects: 1063
Study: 24382970

Group type: EXPERIMENTAL
Intervention: CIK cell treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 21804427

Group type: EXPERIMENTAL
Intervention: Abdominal exercise group (AG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study: 19484630

Group type: EXPERIMENTAL
Intervention: Yoked prisms
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 16673014

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 70
Study: 14676677

Group type: EXPERIMENTAL
Intervention: Cemented hip arthroplasty (Group 1)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-cemented hip arthroplasty (Group 2)
Number of subjects: 35
Study: 10982571

Group type: EXPERIMENTAL
Intervention: TV anti-smoking advertising (TV media)
Number of subjects: 5468

Group type: EXPERIMENTAL
Intervention: TV anti-smoking advertising plus locally organised anti-tobacco campaigning (TV media + LTCN)
Number of subjects: 5468

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 5468

Group type: EXPERIMENTAL
Intervention: TV media only and TV media + LTCN combined
Number of subjects: 5468
Study: 8807183

Group type: EXPERIMENTAL
Intervention: PCORA (Patient Controlled Oral Analgesia)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CPPT (Customarily Prescribed Pain Therapy)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PCORA
Number of subjects: 20

Group type: COMPARATOR
Intervention: CPPT
Number of subjects: 20
Study: 1679661

Group type: EXPERIMENTAL
Intervention: Intravenous celiprolol (8 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (20 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination therapy (celiprolol and nifedipine)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous celiprolol (8 mg) during exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (20 mg) during exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination therapy during exercise
Number of subjects: 30
Study: 6622436

Group type: EXPERIMENTAL
Intervention: 8-week group cholesterol reduction program (nonpharmacologic, behavioral education)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 30514115

Group type: EXPERIMENTAL
Intervention: Group exercises (strength and aerobic exercises) performed twice a week for 24 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual routine (control group)
Number of subjects: 52
Study: 28245247

Group type: EXPERIMENTAL
Intervention: Decision support system (non-obtrusive, integrated in workflow)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Control group (no decision support system)
Number of subjects: 781
Study: 26905112

Group type: EXPERIMENTAL
Intervention: Neo-adjuvant chemotherapy (5 fluorouracil, adriamycin, and cyclophosphamide) followed by modified radical mastectomy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy after modified radical mastectomy
Number of subjects: 31
Study: 24942155

Group type: EXPERIMENTAL
Intervention: Chronic low-dose recombinant human follicle-stimulating hormone (r-hFSH) protocol (starting daily dose: 75 IU, dose increase on Day 14)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human follicle-stimulating hormone (r-hFSH) protocol (starting daily dose: 75 IU, dose increase on Day 7)
Number of subjects: 247
Study: 22944480

Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 299
Study: 20065991

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) superimposed on progressive resistance training (PRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 20
Study: 18635497

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Plasmalyte
Number of subjects: 90
Study: 15884025

Group type: EXPERIMENTAL
Intervention: PRO‐SELF(c) Pain Control Program
Number of subjects: 0
Study: 12039482

Group type: EXPERIMENTAL
Intervention: Primary coronary angioplasty
Number of subjects: 87

Group type: COMPARATOR
Intervention: Intravenous (IV) streptokinase
Number of subjects: 87
Study: 10627728

Group type: EXPERIMENTAL
Intervention: Increased levels of interleukin-6 in patients with total hip arthroplasty more than 10 years ago
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects without total hip arthroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with a prosthesis in place for less than 6 years
Number of subjects: 0
Study: 8749332

Group type: EXPERIMENTAL
Intervention: Rigid contact lenses
Number of subjects: 32

Group type: COMPARATOR
Intervention: Soft contact lenses
Number of subjects: 32
Study: 2537560

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 781231

Group type: EXPERIMENTAL
Intervention: Fenoprofen (2.4 gm/day)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Aspirin (3.9 gm/day)
Number of subjects: 216
Study: 31511862

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB)
Number of subjects: 1976

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 1976
Study: 30904879

Group type: EXPERIMENTAL
Intervention: Manipulation and surgical fixation with K‐wires
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manipulation and plaster casting
Number of subjects: 0
Study: 28258582

Group type: EXPERIMENTAL
Intervention: Cesarean delivery
Number of subjects: 2791

Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 2791
Study: 26382562

Group type: EXPERIMENTAL
Intervention: Diode laser adjunct treatment (1.0 W power, pulsed mode, λ 810 nm, energy density 3 J/cm², time 1 min, power density 400 mW/cm², energy 1.5 J, spot diameter 1 mm)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional scaling and debridement (control group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups (laser and control)
Number of subjects: 10
Study: 23414253

Group type: EXPERIMENTAL
Intervention: SBP + BAI
Number of subjects: 252

Group type: COMPARATOR
Intervention: SBP
Number of subjects: 252
Study: 20438562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vardenafil (10 mg)
Number of subjects: 80
Study: 19198647

Group type: COMPARATOR
Intervention: Control: energy intake at 100% of energy requirements
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CR: 25% calorie restriction
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CR+EX: 12.5% CR plus 12.5% increase in energy expenditure by structured exercise
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: LCD: low calorie diet (890 kcal/d) until 15% weight reduction followed by weight maintenance
Number of subjects: 48
Study: 22373499

Group type: EXPERIMENTAL
Intervention: Feedback group
Number of subjects: 54

Group type: COMPARATOR
Intervention: No feedback group
Number of subjects: 54
Study: 15988144

Group type: EXPERIMENTAL
Intervention: Radiation-associated AML
Number of subjects: 53

Group type: COMPARATOR
Intervention: Spontaneous AML (Control)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Radiation exposure
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Age stratification
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MDS following radiation exposure
Number of subjects: 53
Study: 12882773

Group type: EXPERIMENTAL
Intervention: Best corrected logMAR visual acuity measured at baseline and 1 month later using ETDRS logMAR charts.
Number of subjects: 86
Study: 9619885

Group type: EXPERIMENTAL
Intervention: Rheumatoid Arthritis leaflet
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 84
Study: 7642848

Group type: COMPARATOR
Intervention: Angina-guided strategy (n = 183)
Number of subjects: 558

Group type: COMPARATOR
Intervention: Ischemia-guided strategy (n = 183)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Revascularization strategy (n = 192)
Number of subjects: 558

Group type: COMPARATOR
Intervention: Angina-guided strategy
Number of subjects: 558

Group type: COMPARATOR
Intervention: Ischemia-guided strategy
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Revascularization strategy
Number of subjects: 558
Study: 2505642

Group type: EXPERIMENTAL
Intervention: Atropine 10 micrograms/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 5 micrograms/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (saline)
Number of subjects: 24
Study: 1070220

Group type: EXPERIMENTAL
Intervention: Elema 588 B electrodes
Number of subjects: 159

Group type: COMPARATOR
Intervention: Chardack 5818 electrodes
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Patients with heart disease
Number of subjects: 159
Study: 12185398

Group type: EXPERIMENTAL
Intervention: Diazepam (15 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 31012564

Group type: EXPERIMENTAL
Intervention: Calcipotriene-Betamethasone Dipropionate Aerosol Foam (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcipotriene-Betamethasone Dipropionate Aerosol Foam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (Control)
Number of subjects: 0
Study: 28639445

Group type: EXPERIMENTAL
Intervention: PRO group (periodized training)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FRE group (free training)
Number of subjects: 30

Group type: COMPARATOR
Intervention: UNI group (uniform training)
Number of subjects: 30
Study: 27863602

Group type: EXPERIMENTAL
Intervention: Fordyce Happiness Model (FHM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 140
Study: 25046945

Group type: EXPERIMENTAL
Intervention: Chinese Compound Shenhuang Ointment (CSO)
Number of subjects: 220
Study: 23217267

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp30)
Number of subjects: 6323

Group type: EXPERIMENTAL
Intervention: BIAsp30
Number of subjects: 6323
Study: 20460999

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (30 ml)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ropivacaine 0.375% (20 ml)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ropivacaine concentration increase
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (ED(volume)50/ED(volume)95)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ropivacaine 20 ml (ED(concentration)50/ED(concentration)95)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Ropivacaine doses
Number of subjects: 103
Study: 18723862

Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation programme
Number of subjects: 229

Group type: COMPARATOR
Intervention: Day rehabilitation programme
Number of subjects: 229
Study: 16378790

Group type: EXPERIMENTAL
Intervention: Electronic educational detailing
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Direct (face‐to‐face) educational detailing
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Combination of electronic and direct detailing
Number of subjects: 884

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 884
Study: 12381335

Group type: EXPERIMENTAL
Intervention: Deltatrac calorimeter with disposable standard‐bore air tube and filter
Number of subjects: 11

Group type: COMPARATOR
Intervention: Deltatrac calorimeter with standard wide‐bore tubing
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 11
Study: 9527978

Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., clarithromycin 500 mg b.i.d.)
Number of subjects: 88

Group type: COMPARATOR
Intervention: OMA (omeprazole 20 mg b.i.d., metronidazole 500 mg b.i.d., amoxycillin 1 g b.i.d.)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: OMC
Number of subjects: 88

Group type: COMPARATOR
Intervention: OMA
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Eradication of H. pylori
Number of subjects: 88
Study: 7639092

Group type: EXPERIMENTAL
Intervention: Citalopram (20-60 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2702968

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 911706

Group type: EXPERIMENTAL
Intervention: Iron supplements
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Iron+folate supplements
Number of subjects: 64

Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Nineteen women not included in the trial
Number of subjects: 64
Study: 31476826

Group type: EXPERIMENTAL
Intervention: Targeted SMS reminders
Number of subjects: 138

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 138
Study: 28657655

Group type: EXPERIMENTAL
Intervention: Nail polish (P)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonpolished (NP) fingernails (C)
Number of subjects: 21
Study: 26549589

Group type: EXPERIMENTAL
Intervention: sorafenib (400 mg twice daily)
Number of subjects: 267

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 267
Study: 23929659

Group type: EXPERIMENTAL
Intervention: Darexaban 20 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Darexaban 60 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Darexaban 120 mg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Darexaban 240 mg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 21248382

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation using a generalized transfer function that maps EMG activity into a stimulation pattern.
Number of subjects: 0
Study: 19631122

Group type: EXPERIMENTAL
Intervention: Stromal hydration with balanced salt solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: No stromal hydration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Stromal hydration
Number of subjects: 30
Study: 16339833

Group type: EXPERIMENTAL
Intervention: Standardized hyperventilation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standardized handgrip
Number of subjects: 16
Study: 15552725

Group type: EXPERIMENTAL
Intervention: T1-weighted spin-echo imaging (T1-SE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: T1-weighted opposed-phase gradient-echo imaging (T1-opposed GRE)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Comparison between T1-SE and T1-opposed GRE
Number of subjects: 48
Study: 10982755

Group type: EXPERIMENTAL
Intervention: 5 mg risedronate (n = 255)
Number of subjects: 515

Group type: COMPARATOR
Intervention: 10 mg alendronate (n = 260)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: 5 mg risedronate
Number of subjects: 515

Group type: COMPARATOR
Intervention: 10 mg alendronate
Number of subjects: 515
Study: 8981708

Group type: EXPERIMENTAL
Intervention: Alredase (intervention)
Number of subjects: 3679

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 3679
Study: 1282602

Group type: EXPERIMENTAL
Intervention: Atenolol (62.5 micrograms/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (62.5 micrograms/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pindolol (7.5 micrograms/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Combined EPI and atropine (15 micrograms/kg) after placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: EPI and atropine
Number of subjects: 10
Study: 6325065

Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31075150

Group type: EXPERIMENTAL
Intervention: Standards-Based Management and Recognition (SBM-R) approach in intervention zones
Number of subjects: 426

Group type: COMPARATOR
Intervention: Comparison zones
Number of subjects: 426
Study: 30066362

Group type: COMPARATOR
Intervention: Control group (questionnaire every 4 days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Self-monitoring group (questionnaire + 'say no' to indulgences)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Self-monitoring and feedback group (questionnaire + 'say no' + feedback)
Number of subjects: 45
Study: 27799644

Group type: EXPERIMENTAL
Intervention: CHoBI7 intervention (handwashing with soap and water treatment during hospital stay and home visits)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 604
Study: 25239292

Group type: EXPERIMENTAL
Intervention: Trained by schoolteachers in basic first aid
Number of subjects: 285

Group type: COMPARATOR
Intervention: Untrained (control group)
Number of subjects: 285
Study: 22790403

Group type: EXPERIMENTAL
Intervention: Trimetazidine (60 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 19932167

Group type: EXPERIMENTAL
Intervention: Homozygous carriers of the AluYb8MYH mutation
Number of subjects: 1708
Study: 17380213

Group type: EXPERIMENTAL
Intervention: Amlodipine besylate and atorvastatin calcium single-pill combination (5 or 10 mg amlodipine and 10 mg atorvastatin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine besylate and atorvastatin calcium single-pill combination
Number of subjects: 0
Study: 15674307

Group type: EXPERIMENTAL
Intervention: CLA supplementation (3g/day; 50:50 mix of the two major isomers)
Number of subjects: 28

Group type: COMPARATOR
Intervention: High oleic sunflower oil (reference)
Number of subjects: 28
Study: 14622675

Group type: EXPERIMENTAL
Intervention: Music therapy intervention
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sensory information intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 45
Study: 10233185

Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg b.d. orally
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8966140

Group type: EXPERIMENTAL
Intervention: Intravenous 25% magnesium sulphate infusion (20 ml dissolved in 500 ml 5% dextrose for 60 minutes)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 43